Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab. [electronic resource]
Producer: 20110809Description: 211-21 p. digitalISSN:- 1423-0267
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Female
- Follow-Up Studies
- Humans
- Incidence
- Intravitreal Injections
- Male
- Peripheral Arterial Disease -- chemically induced
- Portugal -- epidemiology
- Ranibizumab
- Retrospective Studies
- Thromboembolism -- chemically induced
- Wet Macular Degeneration -- complications
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.